Previous studies have shown that mutations (missense, small insertions, and deletions) in CSRP3 are associated with hypertrophic cardiomyopathy (HCM)4,5 and dilated cardiomyopathy (DCM)6 in humans. Here, CSRP3 is linked to hypertrophic cardiomyopathy.